✦ LIBER ✦

Methylphenidate treatment of patients with head and neck cancer

✍ Scribed by Fernandez, Francisco ;Adams, Frank

Publisher: Wiley (John Wiley & Sons)
Year: 2006
Weight: 491 KB
Volume: 8
Category: Article
ISSN: 0148-6403
DOI: 10.1002/hed.2890080410

No coin nor oath required. For personal study only.

✦ Synopsis

Five organically impaired and depressed head and neck cancer patients had a marked therapeutic response to methylphenidate (MPD). There was a rapid remission of depressive and cognitive dysfunctions without adverse side effects. The relationship of cognitive, behavioral, and affective symptoms to brain function is discussed. To rule out treatable cognitive and affective disorders, neurobehavioral assessment of the depressed head and neck cancer patient is stressed, and diagnostic and treatment guidelines are given. The results suggest that further evaluation is warranted of the use of MPD in treating seriously ill cancer patients who have either compromised brain function or depression.

📜 SIMILAR VOLUMES

Survival of patients with palliative hea

Survival of patients with palliative head and neck cancer

✍ Quirine C. P. Ledeboer; Marc P. van der Schroeff; Jean F. A. Pruyn; Maarten F. d 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 296 KB 👁 1 views

## Abstract ## Background The purpose of this study was to describe patient characteristics and prognostic factors for survival in the palliative stage of patients with head and neck cancer. ## Methods Since November 2003, all patients with palliative head and neck cancer treated in our hospital

Prioritizing treatment outcomes: Head an

Prioritizing treatment outcomes: Head and neck cancer patients versus nonpatients

✍ Marcy A. List; Judith Lee Rutherford; John Stracks; Barbara Roa Pauloski; Jerily 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

## Abstract ## Background. Treatment decisions in head and neck cancer (HNC) might involve consideration of uncertain tradeoffs of one late effect against another or increasing toxicity or residual impairment for increased chance of survival. Understanding how patients prioritize potential outcome

Prediction of survival in patients with

Prediction of survival in patients with head and neck cancer

✍ Robert Jan Baatenburg de Jong; Jo Hermans; Jan Molenaar; Jeroen Johannes Briaire 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB 👁 2 views

## Background: In patients with head and neck squamous cell carcinoma (hnscc) the estimated prognosis is usually based on the tnm classification. the relative weight of the three contributing parameters is often not completely clear. moreover, the impact of other important clinical variables such a

Mechanisms of hypercalcemia in patients

Mechanisms of hypercalcemia in patients with head and neck cancer

✍ Angel, Michael F. ;Stewart, Andrew ;Pensak, Myles L. ;Pillsbury, Harold R. C. ;S 📂 Article 📅 1982 🏛 Wiley (John Wiley & Sons) ⚖ 491 KB 👁 1 views

## Abstract Hypercalcemia associated with head and neck malignancy is not an uncommon occurrence; its causes are multiple. Eight hypercalcemic patients with head and neck malignancy were studied. Serum calcium, serum phosphorus, tubular phosphorus threshold, fasting calcium excretion, plasma 1,25‐d

Outcomes following reirradiation of pati

Outcomes following reirradiation of patients with head and neck cancer

✍ David P. Goldstein; Lucy Hynds Karnell; Min Yao; G. Parker Chamberlin; Thanh X. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 1 views

## Abstract ## Background This study reports the outcomes for patients with head and neck cancer who received reirradiation with palliative or curative intent. ## Methods A retrospective review of 41 patients treated with curative (__n__ = 28) or palliative (__n__ = 13) reirradiation was conduct

Second neoplasm in patients with head an

Second neoplasm in patients with head and neck cancer

✍ Xavier León; Miquel Quer; Santiago Diez; Cesar Orús; Antonio López-Pousa; Joaqui 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

Background. The improvement in locoregional control of head and neck carcinomas over the last decades does not appear to modify the final survival of these patients, mainly due to the appearance of distant metastases and second neoplasms. We ran a study to evaluate the incidence of second neoplasms